A detailed history of International Biotechnology Trust PLC transactions in I Mab stock. As of the latest transaction made, International Biotechnology Trust PLC holds 310,499 shares of IMAB stock, worth $301,184. This represents 0.14% of its overall portfolio holdings.

Number of Shares
310,499
Previous 310,499 -0.0%
Holding current value
$301,184
Previous $928,000 55.93%
% of portfolio
0.14%
Previous 0.29%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

SELL
$3.22 - $4.86 $633,502 - $956,156
-196,740 Reduced 38.79%
310,499 $1.3 Million
Q3 2022

Nov 08, 2022

BUY
$4.01 - $12.34 $2.01 Million - $6.18 Million
501,007 Added 8039.27%
507,239 $2.02 Million
Q2 2022

Aug 16, 2022

SELL
$8.27 - $18.43 $97,321 - $216,884
-11,768 Reduced 65.38%
6,232 $553 Million
Q3 2021

Nov 12, 2021

BUY
$57.18 - $84.43 $686,160 - $1.01 Million
12,000 Added 200.0%
18,000 $1.3 Million
Q2 2021

Aug 11, 2021

SELL
$47.86 - $83.95 $1.39 Million - $2.43 Million
-29,000 Reduced 82.86%
6,000 $503,000
Q1 2021

May 17, 2021

BUY
$44.38 - $63.97 $1.55 Million - $2.24 Million
35,000 New
35,000 $1.69 Million

Others Institutions Holding IMAB

About I-Mab


  • Ticker IMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,098,800
  • Market Cap $80.6M
  • Description
  • I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...
More about IMAB
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.